StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv gross margin

Gross margin is gross profit as a percentage of revenue.

Pharma-Bio Serv's gross margin for the twelve months ending Jul 31, 2026 was 32.3%. For fiscal 2025 it was 32.3%, against 26.5% the year before. The highest annual figure on record is 35.8% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Oct 31, 202532.3%+5.9
FY2024Oct 31, 202426.5%−3.4
FY2023Oct 31, 202329.8%+4.7
FY2022Oct 31, 202225.2%−1.5
FY2021Oct 31, 202126.6%−4.3
FY2020Oct 31, 202030.9%−0.7
FY2019Oct 31, 201931.7%−0.3
FY2018Oct 31, 201832.0%+3.1
FY2017Oct 31, 201728.9%−0.7
FY2016Oct 31, 201629.6%−2.4
FY2015Oct 31, 201532.0%−0.6
FY2014Oct 31, 201432.6%−3.2
FY2013Oct 31, 201335.8%+2.0
FY2012Oct 31, 201233.8%−0.6
FY2011Oct 31, 201134.4%+4.5
FY2010Oct 31, 201029.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jul 31, 202629.6%+0.4
Q2 FY2026CQ1 2026Apr 30, 202633.4%−0.5
Q1 FY2026CQ4 2025Jan 31, 202631.5%+0.4
Q4 FY2025CQ3 2025Oct 31, 202534.8%+3.7
Q3 FY2025CQ2 2025Jul 31, 202529.3%+3.0
Q2 FY2025CQ1 2025Apr 30, 202533.9%+7.9
Q1 FY2025CQ4 2024Jan 31, 202531.1%+8.6
Q4 FY2024CQ3 2024Oct 31, 202431.1%+5.3
Q3 FY2024CQ2 2024Jul 31, 202426.3%−7.6
Q2 FY2024CQ1 2024Apr 30, 202426.0%−3.5
Q1 FY2024CQ4 2023Jan 31, 202422.5%−6.8
Q4 FY2023CQ3 2023Oct 31, 202325.8%+0.3
Q3 FY2023CQ2 2023Jul 31, 202333.9%+7.1
Q2 FY2023CQ1 2023Apr 30, 202329.5%+4.3
Q1 FY2023CQ4 2022Jan 31, 202329.3%+3.7
Q1 FY2022CQ4 2021Jul 31, 202225.6%−3.7
Q4 FY2021CQ3 2021Oct 31, 202126.8%−0.2
Q3 FY2021CQ2 2021Jul 31, 202125.2%−4.4
Q2 FY2021CQ1 2021Apr 30, 202125.6%−7.5
Q1 FY2021CQ4 2020Jan 31, 202129.3%−5.1
Q4 FY2020CQ3 2020Oct 31, 202027.0%−4.9
Q3 FY2020CQ2 2020Jul 31, 202029.5%−2.0
Q2 FY2020CQ1 2020Apr 30, 202033.1%+2.2
Q1 FY2020CQ4 2019Jan 31, 202034.4%+2.0
Q4 FY2019CQ3 2019Oct 31, 201931.9%−1.1
Q3 FY2019CQ2 2019Jul 31, 201931.5%−2.9
Q2 FY2019CQ1 2019Apr 30, 201930.9%+3.4
Q1 FY2019CQ4 2018Jan 31, 201932.4%+0.7
Q4 FY2018CQ3 2018Oct 31, 201833.0%−29.2
Q3 FY2018CQ2 2018Jul 31, 201834.4%+11.1
Q2 FY2018CQ1 2018Apr 30, 201827.5%+1.0
Q1 FY2018CQ4 2017Jan 31, 201831.7%+6.2
Q4 FY2017CQ3 2017Oct 31, 201762.3%+39.1
Q3 FY2017CQ2 2017Jul 31, 201723.3%−6.0
Q2 FY2017CQ1 2017Apr 30, 201726.6%–
Q1 FY2017CQ4 2016Jan 31, 201725.5%–
Q4 FY2016CQ3 2016Oct 31, 201623.2%–
Q3 FY2016CQ2 2016Jul 31, 201629.3%–

More Pharma-Bio Serv figures

See a number that looks wrong?